{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:36:20Z","timestamp":1784676980705,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2231,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.bbmt.2008.12.491","type":"journal-article","created":{"date-parts":[[2009,2,8]],"date-time":"2009-02-08T04:29:36Z","timestamp":1234067376000},"page":"370-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Voriconazole-Induced Phototoxicity Masquerading as Chronic Graft-versus-Host Disease of the Skin in Allogeneic Hematopoietic Cell Transplant Recipients"],"prefix":"10.1016","volume":"15","author":[{"given":"Asha R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gea-Banacloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.12.491_bib1","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors","volume":"100","author":"Marr","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.12.491_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2008.12.491_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.12.491_bib4","first-page":"163","article-title":"Results of a randomized, double-blind trial of fluconazole (FLU) vs. voriconazole (VORI) for the prevention of invasive fungal infections (IFI) in 600 allogeneic blood and marrow transplant (BMT) patients","volume":"110","author":"Wingard","year":"2007","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.bbmt.2008.12.491_bib5","unstructured":"Vfend (Voriconazole, Oral and Intravenous Formulations), NDA 21-267, Briefing Document for FDA Antiviral Drugs Advisory Committee Meeting, 4 October 2001. Pfizer Inc. [online]. Available from URL: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3792b2_01_Pfizer.pdf [Accessed 2007 October 18]."},{"key":"10.1016\/j.bbmt.2008.12.491_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1517\/14740338.6.4.431","article-title":"Drug-induced photoallergic and phototoxic reactions","volume":"6","author":"Stein","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bbmt.2008.12.491_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0733-8635(18)30825-8","article-title":"Phototoxicity from systemic agents","volume":"4","author":"Toback","year":"1986","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.bbmt.2008.12.491_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2230.2001.00909.x","article-title":"Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole","volume":"26","author":"Denning","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children","volume":"21","author":"Walsh","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bbmt.2008.12.491_bib10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/375235","article-title":"Successful treatment of coccidioidal meningitis with voriconazole","volume":"36","author":"Cortez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2008.12.491_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10096-004-1176-7","article-title":"Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole","volume":"23","author":"Vandecasteele","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bbmt.2008.12.491_bib12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.0736-8046.2004.21614.x","article-title":"Voriconazole-induced retinoid-like photosensitivity in children","volume":"21","author":"Rubenstein","year":"2004","journal-title":"Pediatr Dermatol"},{"issue":"5 Suppl. 1","key":"10.1016\/j.bbmt.2008.12.491_bib13","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.jaad.2004.07.034","article-title":"Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl","volume":"52","author":"Racette","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcf.2005.05.019","article-title":"Voriconazole therapy in children with cystic fibrosis","volume":"4","author":"Hilliard","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bbmt.2008.12.491_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0151-9638(06)70910-3","article-title":"Voriconazole photosensitivity: 7 cases [in French]","volume":"133","author":"Auffret","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1130-6343(06)74012-0","article-title":"Voriconazole-associated phototoxicity [in Spanish]","volume":"30","author":"Serra Soler","year":"2006","journal-title":"Farm Hosp"},{"key":"10.1016\/j.bbmt.2008.12.491_bib17","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1086\/511685","article-title":"Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy","volume":"44","author":"McCarthy","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2008.12.491_bib18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-4632.2004.02177.x","article-title":"Pseudoporphyria as a result of voriconazole use: a case report","volume":"43","author":"Dolan","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jaad.2005.03.030","article-title":"Pseudoporphyria induced by Voriconazole","volume":"53","author":"Sharp","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0781.2007.00263.x","article-title":"Voriconazole-induced pseudoporphyria","volume":"23","author":"Tolland","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.bbmt.2008.12.491_bib21","first-page":"1042","article-title":"Pseudoporphyria associated with voriconazole","volume":"6","author":"Kwong","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib22","series-title":"Skin Pathology","first-page":"46","article-title":"The lichenoid reaction pattern (\u201cinterface dermatitis\u201d)","author":"Weedon","year":"2002"},{"key":"10.1016\/j.bbmt.2008.12.491_bib23","series-title":"Skin Pathology","first-page":"600","article-title":"Reactions to physical agents","author":"Weedon","year":"2002"},{"key":"10.1016\/j.bbmt.2008.12.491_bib24","series-title":"Pathology of the Skin","first-page":"204","article-title":"Interface dermatitis","author":"Hood","year":"2000"},{"key":"10.1016\/j.bbmt.2008.12.491_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archderm.137.1.75","article-title":"The \u201cdrug vs graft-vs-host disease\u201d conundrum gets tougher, but there is an answer: the challenge to dermatologists","volume":"137","author":"Nghiem","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.12.491_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2008.12.491_bib28","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2165\/00003495-200464180-00001","article-title":"Newer systemic antifungal agents: pharmacokinetics, safety and efficacy","volume":"64","author":"Boucher","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2008.12.491_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/510677","article-title":"Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts","volume":"44","author":"Segal","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2008.12.491_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.491_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF00376823","article-title":"Graft-versus-host reaction enhanced by ultraviolet radiation","volume":"285","author":"Kitajima","year":"1993","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.bbmt.2008.12.491_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archderm.136.7.849","article-title":"Antibiotic rashes in children: a survey in a private practice setting","volume":"136","author":"Ibia","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0895-4356(98)00041-9","article-title":"Skin reactions to antibacterial agents in general practice","volume":"51","author":"van der Linden","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.bbmt.2008.12.491_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0031-6997(24)01501-1","article-title":"Cutaneous drug reactions","volume":"53","author":"Svensson","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bbmt.2008.12.491_bib35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.491_bib36","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108010987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108010987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:33:11Z","timestamp":1761057191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108010987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1083879108010987"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.491","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voriconazole-Induced Phototoxicity Masquerading as Chronic Graft-versus-Host Disease of the Skin in Allogeneic Hematopoietic Cell Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}